NOVEL DRUG DELIVERY 2020

Jun 22-23, 2020

|

Chicago, United States of America

Novel Drug Delivery Systems Congress 2020

LexisConferences conferences Ltd is very excited to welcome participants to Chicago, the USA at Novel Drug Delivery Systems Congress 2020 scheduled during June 22-23, 2020.

Novel Drug Delivery 2020 will illustrate innovative research ideas on Advanced Drug Delivery Systems, Drug Targeting and Design, Nanomedicine & Nanotechnology, Pharmaceutical Technology, Medicinal Chemistry and Drug Discovery and Screening, Formulation Technology, Biopharmaceutics and Biologics Drugs, Medical Devices for Drug Delivery. This conference presents a fantastic line-up for many international experts such as Professors and PhD Scholars from academia, Clinicians, R&D Scientists, CEOs, CROs, CMOs, Director, President from Pharmaceutical Companies, Manufacturers, Distributors and Suppliers of Drug Delivery Technologies, Business Entrepreneurs, Health professionals & Pharmacist, Quality control specialist. It provides an interdisciplinary platform to present and discuss the most recent innovations, trends as well as practical challenges encountered and solutions adopted in the fields NDDS.

The global drug delivery systems market was valued approximately US$ 510.0 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. The North America NDDS market is expected to witness a CAGR of 8.7% during the forecast period, 2018-2023. Key companies operating in the global drug delivery systems market and profiled in the report include AstraZeneca plc., Bayer AG, Pfizer, Inc., Novartis AG, Amgen Inc., Johnson and Johnson Services, Inc., Baxter International, Inc., Boston Scientific Corporation, and Becton, Dickinson & Company

Some of the factors driving the growth of the market are:

  • Increased prevalence of chronic diseases
  • Technological advances
  • Increase in individual therapy
  • Increased understanding of drug metabolism among the population
  • The requirement of controlled drug release

 References:

Lucy
Dr Affiong Iyire
School of Life Health Sciences
Aston University, Birmingham, UK

Lucy
Prof Dr Heyam Saad Ali
Pharmaceutics Department
Dubai Pharmacy College, UAE

Biography

Prof. Dr. Heyam Saad Ali, Ph-D –She is working in pharmaceutics department in Dubai Pharmacy College, UAE. Prof. contributed more than 70 articles to reputed international scientific journals and conferences, in different conventional, controlled and targ

Program Overview

Our Collaborations, Sponsors, Media Partners